KBW raises Morgan Stanley price target to $250
Keefe, Bruyette & Woods analyst Christopher McGratty maintained an Outperform rating on Morgan Stanley and raised the price target to $250 from $225, signaling continued confidence in the stock.

*this image is generated using AI for illustrative purposes only.
Keefe, Bruyette & Woods analyst Christopher McGratty has maintained an Outperform rating on Morgan Stanley while raising the stock's price target to $250 from the previous $225. The adjustment reflects a revised outlook on the financial services firm's valuation potential.
Rating and Price Action
The research note from Keefe, Bruyette & Woods reinforces a positive stance on Morgan Stanley shares. The new price target of $250 represents an increase over the prior target of $225, indicating an expectation of further upside.
| Metric | Value |
|---|---|
| Rating | Outperform |
| Previous Price Target | $225 |
| New Price Target | $250 |
What specific valuation metrics or growth drivers justify the increased price target?
How might Morgan Stanley's wealth management segment contribute to achieving this new target?
What are the potential risks to the revised outlook, given current market volatility?

































